AlphAIalphai — Financial news for AI agents
finance.yahoo.comAUG 282 min read$NUTX

Zacks.com featured highlights Nutex, RCM, Remitly and Belden

Zacks.com highlighted four companies with strong net profit margins: Nutex Health (NUTX), RCM Technologies (RCMT), Remitly Global (RELY), and Belden (BDC). Each company's 2026 earnings estimates were revised upward, with NUTX up 32.5%, RCMT up 13.3%, RELY up 13.8%, and BDC up 5.7%. All companies recently beat earnings estimates.

Original reporting
finance.yahoo.com
Published Aug 28, 2026, 7:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 11:38 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Zacks.com featured highlights Nutex, RCM, Remitly and Belden — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$NUTXBullishLow
01

Why it matters

The revisions suggest improved earnings outlooks but are modest in scale, offering limited trading opportunities.

02

Market read

Small positive bias for the highlighted stocks; overall market impact minimal.

03

What to watch

Potential macro headwinds or competitive pressures could offset the modest estimate lifts.

Relevance 5/10Novelty 5/10Timing: today

Background

Zacks' Screen of the Week highlights four stocks with recent upward revisions to 2026 earnings estimates.

Company-level read

Ticker impact

$NUTXBullishMedium confidence
Context

Zacks raised Nutex Health's 2026 earnings estimate by 32.5% to $30.11 per share.

Expected impact

Potential modest price appreciation.

Evidence & confidence

Guidance lift signals improved outlook, but scale is modest.

$RCMTBullishMedium confidence
Context

Zacks increased RCM Technologies' 2026 earnings estimate by 13.3% to $3.07 per share.

Expected impact

Likely limited upside.

Evidence & confidence

Guidance bump is modest; market reaction may be muted.

$RELYBullishMedium confidence
Context

Zacks lifted Remitly Global's 2026 earnings estimate by 13.8% to $1.57 per share.

Expected impact

Small upside possible.

Evidence & confidence

Guidance increase is modest; limited immediate impact.

$BDCNeutralLow confidence
Context

Zacks raised Belden's 2026 earnings estimate by 5.7% to $8.69 per share.

Expected impact

Little to no price movement expected.

Evidence & confidence

Small revision and lower Zacks rank reduce impact.

Market effects

Sector

Highlights modest earnings outlook improvements in healthcare, tech services, remittance, and networking equipment sectors.

Regional

U.S. equity market may see slight positive bias for the four companies.

Global

Limited; primarily U.S.-focused equity investors.

Counterpoint

What could challenge this read

Guidance upgrades may already be priced in; investors could wait for actual earnings.

Key entities

  • Research Firm
    Zacks Investment Research

    Provider of the earnings estimate revisions.

Read at source← All news

Related articles

AUG 26
$TREEMedAI 8/10

Financial Technology Stocks Q2 Teardown: LendingTree (NASDAQ:TREE) Vs The Rest

LendingTree (TREE) reported $313.4M in Q2 revenue, up 25.3% YoY but missing estimates by 0.7%. Its stock fell 22.3% post-earnings. Robinhood (HOOD) saw $1.31B in revenue, up 32.3% YoY, beating estimates by 1.8%, and its stock rose 23.8%. Coinbase (COIN) reported $1.22B in revenue, down 18.5% YoY, missing estimates by 5.9%, yet its stock rose 13.6%. Remitly (RELY) reported $495.2M in revenue, up 20.2% YoY, beating estimates by 1.8%, and its stock rose 9.9%.

stockstory.org3 min
AUG 25
$NUTXMed

Fifth Circuit Rejects "Ghost Rates" in Federal QPA Calculations Under the No Surprises Act

Nutex Health (NASDAQ: NUTX) commented on a Fifth Circuit ruling invalidating federal QPA calculation rules under the No Surprises Act, which the company says artificially deflated payments. The court ruled insurers cannot include non-negotiated 'ghost rates' and must include bonus payments in QPA calculations. Nutex Health expects this to lead to fairer upfront payments for providers. The ruling may impact the company's financials, but the timeline for new regulations is uncertain.

prnewswire.com2 min
AUG 20
$BDCHighAI 8/10

The AI Boom Is Turning This Cable Maker Into a Stock to Watch

Belden (NYSE: BDC) reported record Q2 revenue of $750.2M, up 11.6% YOY, and net income of $68.5M, up 12.3%. The company benefits from AI data center demand and completed a $1.85B acquisition of RUCKUS Networks. Analysts rate it a Buy with an average price target of $156.25, implying 20% upside. Risks include competition and integration challenges.

yahoo.com3 min
AUG 14
$RELYMedAI 8/10

Remitly (RELY) Q2 2026 Earnings Call Transcript

Remitly (RELY) held its Q2 2026 earnings call, reporting record revenue and record adjusted EBITDA, both above the high end of guidance, and over 10 million quarterly active users. It said it added 5 countries to its payout network, nearly 70% of funded transfers delivered in under 20 seconds, and is a founding member of OpenUSD. It also discussed new licenses and product launches including a stablecoin wallet and Global Card.

yahoo.com12 min
AUG 13
$NUTXMedAI 8/10

Nutex Health (NUTX) Q2 2026 Earnings Call Transcript

Nutex Health (NUTX) reported Q2 2026 results on an earnings call. Total revenue fell to $210.8M from $244.0M. Net income rose to $65.8M, diluted EPS to $9.38, and adjusted EBITDA to $90.0M. Management cited lower contract services costs from a HaloMD amendment and higher patient visits, plus a hospital expansion pipeline.

fool.com7 min